Ohio Public Employees Retirement System (OPERS)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
PCH
RI
PHS
Ohio Public Employees Retirement System (OPERS)'s CYTK Position: Q1 2023 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 14,769 shares — an estimated $677K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in CYTK in Q3 2015 and held it in 30 quarters. The position peaked at $3.04M in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 14,769 Cytokinetics shares in Q1 2023, an estimated $677K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Cytokinetics in Q3 2015 and held it in 30 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Cytokinetics position peaked at $3.04M in Q4 2021.
- 262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.